Today, we know much more about why a cell becomes cancerous and about which proteins and genes are responsible for this happening
The Vall d’Hebron Institute of Oncology (VHIO) has published a new study describing a new molecular mechanism that regulates the renewal of the glioma stem cells. The findings represent an important advancement in the research centred on one of the most aggressive brain tumours, the glioblastoma multiforme
Davide Melisi will offer a conference about TGF-ß signaling for anticancer therapies
Christopher Proud, from Southampton University, presents the latest advancements related to mTOR, involved in certain cancers
Antonio Hurtado, from the Cambridge Research Institute, will offer a seminar on the factors that cause resistance to Tamoxifen on breast cancer patients
It is the first National Agreement that includes the Academic environment, basic research, clinical research and the pharmaceutical industry
The “Olga Torres” Foundation awards to a VHIO research group a grant for the research on tumor stem cells
Arkaitz Carracedo, from the Harvard Medical School, gives a lecture on the latest developments on potential therapy for cancer
According to the Director of VHIO, “the race in research against cancer has only just begun”
José Baselga and Josep Tabernero directly participate in the study, directed by William Hahn, of the Dana-Farber Cancer Institute of Boston
VHIO Scientific Manager is a pioneer in translational research
Queen Sofía and Councillor Marina Geli assist at the opening ceremony
